The odds of receiving first-line (FL) antibiotic therapy at pediatric urgent care centers (PUCs) were lower in White children ...
A population-wide cohort study in Ontario found that more than 15% of residents colonized with resistant bacteria went on to ...
Some DeKalb County voters are hitting the polls again today for a few runoff elections. Polls are open until 7 p.m.
About 15 million, or 37% of Canada’s 40 million people, live in the Vancouver, Toronto, and Montreal areas, three of the top ...
一品红 (300723.SZ)公告,公司全资子公司广州一品红制药有限公司于近日收到国家药品监督管理局核准签发的关于利奈唑胺干混悬剂的《药品注册证书》。 公告显示,利奈唑胺属于噁唑烷酮类合成抗生素,可用于治疗新生儿、儿童及成人由需氧的革兰阳性菌引起的感染,包括院内获得性肺炎 (HAP)、社区获得性肺炎 (CAP)、复杂性皮肤和皮肤软组织感染 (SSTI)、非复杂性皮肤和皮肤软组织感染 ...
Trevor Lawrence faces a tough recovery following a severe hit by Aziz Al-Shaair, marking his second concussion. Careful steps are planned for his comeback. Yemen Houthis Hit U.S Destroyer, Supply ...
【来源:中国证券报】中证智能财讯 一品红(300723)12月3日午间公告,公司全资子公司广州一品红制药有限公司、广州市联瑞制药有限公司分别于近日收到国家药监局核准签发的关于利奈唑胺干混悬剂、培哚普利氨氯地平片(Ⅲ)的《药品注册证书》。
近日,一品红收到国家药品监督管理局核准签发的关于利奈唑胺干混悬剂的《药品注册证书》。本次获批的利奈唑胺干混悬剂是以化学药品3类申报注册,视同通过一致性评价。 干混悬剂型,服用方便,尤其适合儿童、老人、吞咽困难者等特殊人群使用,可行序贯治疗。国内目前上市的利奈唑胺有注射液、片剂和干混悬剂三种剂型,公司获批的利奈唑胺干混悬剂属第二家过评产品。 主要信息 药品通用名称: 利奈唑胺干混悬剂 剂型: 口服混 ...